Table 4.
Administration of radiochemotherapy
| |
Dose level |
|
||
|---|---|---|---|---|
| 1 | 2 | 3 | Total | |
| Number of patients |
4 (100%) |
13 (100%) |
7 (100%) |
24 (100%) |
| Chemotherapy delay? |
|
|
|
|
| No |
3 (75%) |
5 (38%) |
5 (71%) |
13 (54%) |
| Yes |
1 (25%) |
8 (62%) |
2 (29%) |
11 (46%) |
| If yes, reason for delay: |
|
|
|
|
| Administrative reason |
1 (100%) |
4 (50%) |
1 (50%) |
6 (55%) |
| Adverse event |
|
4 (50%) |
1 (50%) |
5 (45%) |
| Chemotherapy reduction? |
|
|
|
|
| No |
3 (75%) |
11 (85%) |
6 (86%) |
20 (83%) |
| Yes |
1 (25%) |
2 (15%) |
1 (14%) |
4 (17%) |
| If so, reason for reduction: |
|
|
|
|
| Administrative reason |
|
1 (50%) |
|
1 (25%) |
| Adverse event |
1 (100%) |
1 (50%) |
1 (100%) |
3 (75%) |
| Radiotherapy total dose (Gy) |
|
|
|
|
| Mean (SD) |
46.8 (4.41) |
44.45 (10.68) |
46.54 (2.63) |
45.45 (8.07) |
| Median (range) | 47.7 (41.4–50.4) | 45.0 (10.8–50.4) | 45.0 (45.0–50.4) | 45.0 (10.8–50.4) |